These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 8318410)

  • 1. Melphalan sensitivity as a function of progressive metastatic growth in two subpopulations of a mouse mammary tumour.
    Miller BE; Miller FR; Machemer T; Heppner GH
    Br J Cancer; 1993 Jul; 68(1):18-25. PubMed ID: 8318410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential influence of organ site on three subpopulations of a single mouse mammary tumor at two distinct steps in metastasis.
    Aslakson CJ; Rak JW; Miller BE; Miller FR
    Int J Cancer; 1991 Feb; 47(3):466-72. PubMed ID: 1993557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor subpopulation interactions affecting melphalan sensitivity in palpable mouse mammary tumors.
    Miller BE; Machemer T; Lehotan M; Heppner GH
    Cancer Res; 1991 Aug; 51(16):4378-87. PubMed ID: 1868461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of tumour cell composition in tumours composed of paired mixtures of mammary tumour cell lines.
    Miller BE; Miller FR; Wilburn DJ; Heppner GH
    Br J Cancer; 1987 Nov; 56(5):561-9. PubMed ID: 3426919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clonal variation in the sensitivity of a murine mammary carcinoma to melphalan.
    McMillan TJ; Stephens TC; Steel GG
    Br J Cancer; 1986 Jun; 53(6):753-9. PubMed ID: 3718828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors affecting growth and drug sensitivity of mouse mammary tumor lines in collagen gel cultures.
    Miller BE; Miller FR; Heppner GH
    Cancer Res; 1985 Sep; 45(9):4200-5. PubMed ID: 4028010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metastasis of murine mammary tumour lines from the mammary gland and ectopic sites.
    Unemori EN; Ways N; Pitelka DR
    Br J Cancer; 1984 May; 49(5):603-14. PubMed ID: 6722008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. beta-cyclodextrin tetradecasulfate/tetrahydrocortisol +/- minocycline as modulators of cancer therapies in vitro and in vivo against primary and metastatic Lewis lung carcinoma.
    Teicher BA; Sotomayor EA; Huang ZD; Ara G; Holden S; Khandekar V; Chen YN
    Cancer Chemother Pharmacol; 1993; 33(3):229-38. PubMed ID: 8269604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mixed inocula of mouse mammary tumour cell subpopulations result in changes of organ-specific metastasis.
    Hossain A; Sarkar A; Sarkar NH
    Clin Exp Metastasis; 1991; 9(6):501-15. PubMed ID: 1752081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequential alteration of peanut agglutinin binding-glycoprotein expression during progression of murine mammary neoplasia.
    Rak JW; McEachern D; Miller FR
    Br J Cancer; 1992 May; 65(5):641-8. PubMed ID: 1586590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of metastatic cell lines derived from a murine mammary tumour, and reduction of metastasis by heparin.
    Lee AE; Rogers LA; Jeffery RE; Longcroft JM
    Clin Exp Metastasis; 1988; 6(6):463-71. PubMed ID: 3409560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor subpopulation interactions in metastasis.
    Miller FR
    Invasion Metastasis; 1983; 3(4):234-42. PubMed ID: 6677628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of in vivo tumor response to chemotherapeutic agents by the in vitro sister chromatid exchange assay.
    Tofilon PJ; Basic I; Milas L
    Cancer Res; 1985 May; 45(5):2025-30. PubMed ID: 4039220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The colony forming efficiency of single cells and cell aggregates from a spontaneous mouse mammary tumour using the lung colony assay.
    Thompson SC
    Br J Cancer; 1974 Oct; 30(4):332-6. PubMed ID: 4141261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Host distribution and response to antitumor alkylating agents of EMT-6 tumor cells from subcutaneous tumor implants.
    Holden SA; Emi Y; Kakeji Y; Northey D; Teicher BA
    Cancer Chemother Pharmacol; 1997; 40(1):87-93. PubMed ID: 9137536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spontaneous fusion between metastatic mammary tumor subpopulations.
    Miller FR; McInerney D; Rogers C; Miller BE
    J Cell Biochem; 1988 Feb; 36(2):129-36. PubMed ID: 3356752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute in vivo resistance in high-dose therapy.
    Teicher BA; Ara G; Keyes SR; Herbst RS; Frei E
    Clin Cancer Res; 1998 Feb; 4(2):483-91. PubMed ID: 9516940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic perturbation of the tumor ecosystem in reconstructed heterogeneous mouse mammary tumors.
    Miller BE; Miller FR; Heppner GH
    Cancer Res; 1989 Jul; 49(14):3747-53. PubMed ID: 2736515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dominance of a tumor subpopulation line in mixed heterogeneous mouse mammary tumors.
    Miller BE; Miller FR; Wilburn D; Heppner GH
    Cancer Res; 1988 Oct; 48(20):5747-53. PubMed ID: 3167832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin 6 gene-transfected mouse mammary adenocarcinoma: tumour cell growth and metastatic potential.
    Di Carlo E; Modesti A; Castrilli G; Landuzzi L; Allione A; de Giovanni C; Musso T; Musiani P
    J Pathol; 1997 May; 182(1):76-85. PubMed ID: 9227345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.